Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 14, 2021; 27(34): 5682-5699
Published online Sep 14, 2021. doi: 10.3748/wjg.v27.i34.5682
Published online Sep 14, 2021. doi: 10.3748/wjg.v27.i34.5682
Antioxidants and nutrients | Plant and/or animal sources | Potential target pathways | Recommended dietary intake; Effective dose for respiratory infection) | Registered clinical trials of COVID-19, rial number | Intervention dose | Primary outcome |
Vitamin A | Carrots (raw); Cantaloupe; Mango; Salmon; Eggs | Role in immune competence; Immunomodulatory action | 900/700 μg M/F | IRCT20200319046819N1[49] | 25000 IU vitamin A and 600000 IU vitamin D per day, 300 IU vitamin E twice a week, 2000 mg vitamin C 4 times in a day, amp vitamin B; Soluvit in a day, for 1 wk | Weight, height, BMI; Severity of pulmonary involvement (CT scan); Respiratory support (invasive or non-invasive); WBC, CRP, IL6, TNF-α, IFN-γ, ESR; Body temperature; Organ involvement; Hospital duration; Mortality |
Vitamin D | Portabella mushrooms; Dairy products; Eggs; Fish | Maintenance of cell physical barrier integrity; Increased antimicrobial protein production; Anti-inflammatory state; ACE2 and other members of the RAS expression | 5- 15 μg; 20-50 μg[60] | NCT04334005[61] | 25000 IU vitamin D | Mortality, all-cause mortality within 14 d |
NCT04344041[62] | 400000 IU/or 50000 IU | Serum 25(OH)D3 changes during treatment | ||||
NCT04636086[63] | 50000 IU vitamin D ; 25000 IU vitamin D ; Days 1-4, 8,15, 22, 29 and 36 | Vitamin D serum concentration, clinical improvement, biological markers | ||||
NCT04621058[64] | D deficiency (< 30 ng/mL) 0.532 mg vitamin D (< 40 ng/mL): 0.266 mg vitamin D | Mortality reduction, lent of hospital reduction | ||||
NCT04483635[65] | 100000 IU vitamin D tab. baseline + 10000 IU/wk; 16 wk | Change in incidence laboratory-confirmed COVID-19 infection | ||||
NCT04386850[66] | 25 µg 25(OH)D3; 2 mo | Hospitalization, disease duration, death, mortality, ventilation | ||||
Vitamin C | Oranges; Lemon; Green and red peppers; Tomato; Broccoli; Brussel sprouts; Cabbage; Cauliflower; Spinach; Sweet potato; Winter squash | Antioxidant capacity; Immunomodulatory effects on interferon production; Cytokine production down-regulation | 40-80 mg; 6–8 g[77] | NCT04323514[74] | 10 g vitamin C infusion | Hospital mortality |
NCT04530539[75] | 1000 mg vitamin C | Severity of symptoms | ||||
NCT04682574[76] | 30 g/d 2 d with standard treatment | Partial pressure of oxygen in arterial blood to fraction of inspired oxygen | ||||
Vitamin E | Sunflower seeds; Nuts; Almonds; Blueberries; Kivi; Broccoli | Antioxidant action; Immunomodulatory effects | 7–10 mg; 30–200 mg[82] | |||
Zinc | Pumpkin and squash seeds nuts; Soybean; Beef; Mollusks; Lamb | Reduces ROS in viral infections; Replication inhibition; Immunomodulatory effects; Antibody production; NK cell activity; Cytokine production by mononuclear cells; Chemotaxis response reduction; Neutrophil respiratory burst reduction | 8–14 mg; 30–50 mg[43] | NCT04335084[90] | Zinc, vitamin D, vitamin C 12 wk and hydroxychloroquine for 1 d | Prevention of COVID-19 symptoms recorded in a daily diary |
Selenium | Sunflower seeds; Coconut meat; Mollusks; Salmon; Turkey; Ham | Antioxidant balanceROS balance in inflammatory processes | 60–70 mg | |||
Copper | Cashew nuts; Tofu; Mushrooms; Beef; Oyster; Cereals; Roots, tubers: Sweet potato; Quinoa | Role in immunity antimicrobial action due to copper toxicity; Enhance macrophage activity in lung infection | 900 μg | |||
Curcumin | Rhizome of turmeric | Antioxidant capacity; Virus-ACE2 interaction reduction; ACE2 level increase; Antiviral activities SARS-CoV-2 protease, spike glycoprotein-RBD and PD-ACE2 binding | IRCT20200611047735N1[114] | 160 mg curcumin; 2 wk | Immune responses (IFN-γ, IL-17, IL-4 and TGF-β) | |
IRCT20121216011763N46[115] | 1000 mg curcumin + 10 mg piperine twice/day, 2 wk | Clinical symptoms, duration, severity, inflammatory mediators | ||||
Silymarin | Milk thistle (Silybum marianum) | Antioxidant capacity; Anti-inflammatory; p38 MAPK pathway antiviral | NCT04394208[116] | 420 mg/d; 3 divided doses | Clinical outcome duration of mechanical ventilation hospitalization |
- Citation: Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699
- URL: https://www.wjgnet.com/1007-9327/full/v27/i34/5682.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i34.5682